A study on colorectal carcinoma also underscored that upregulation of the SLC2A3 gene was associated with decreased overall and disease-free survival in patients with colorectal cancer, suggesting that determination of SLC2A3 expression might be useful for predicting the prognosis of these patients (Kim et al., 2019). Here, SLC2A3 is linked to colorectal carcinoma.